Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on June 25, 2025
Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech
GlobeNewswire
·
June 25, 2025
Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …
AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand
GlobeNewswire
·
June 25, 2025
New eBee X units enhance capabilities across agriculture, urban planning, and strategic applications WICHITA, Kan., June 25, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging …
BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- As Bitcoin holds steady above $105,000 and Ethereum remains strong beyond $2,500, global investors are increasingly turning to passive income solutions in the crypto sector. Riding this wave is BTC Miner, a …
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
GlobeNewswire
·
June 25, 2025
BERKELEY, Calif. and MAINZ, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its …
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus
GlobeNewswire
·
June 25, 2025
Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s pipeline under the name EVX-B4 Urgent need for preventive …
Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of …
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
GlobeNewswire
·
June 25, 2025
Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …
Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
GlobeNewswire
·
June 25, 2025
– Favorable safety and tolerability profile, as well as pharmacokinetics supporting once-daily oral dosing, continued to be observed in final 400 mg cohort – – Mean plasma HBV DNA reductions of 3.2 logs IU/mL over 28 days of treatment for 400 mg cohort …
Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation
GlobeNewswire
·
June 25, 2025
BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading product experience management (PXM) platform that empowers brands, retailers, and distributors to win on the digital shelf, is thrilled to announce the appointment of Cory McIntyre as Vice …
Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII
GlobeNewswire
·
June 25, 2025
SEATTLE, June 25, 2025 (GLOBE NEWSWIRE) -- Nametag, the leader in workforce identity verification, today announced the general availability of Enterprise Data Custody. Enterprise Data Custody allows organizations to store all personally identifiable …
Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab
GlobeNewswire
·
June 25, 2025
Combination cohort initiated following successful review of monotherapy cohort Over 100 participants dosed to-date in monotherapy cohort Priority are Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer Data update on schedule for later this …
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
GlobeNewswire
·
June 25, 2025
BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that three …
Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile
GlobeNewswire
·
June 25, 2025
New clinical trial data with Bryn Pharma’s second-generation epinephrine nasal spray expected in Q3 2025 The trial employs an upgraded two-spray nasal spray device providing additional reliability and user experience enhancements Trial includes evaluation …
Media Advisory - Energy Sector Gains New Edge in Vegetation and Methane Emissions Monitoring with Maxar and Satelytics Partnership
GlobeNewswire
·
June 25, 2025
PERRYSBURG, Ohio, June 25, 2025 (GLOBE NEWSWIRE) -- Maxar and its partner Satelytics are announcing today an expansion of their offerings to the energy industry. In addition to the methane monitoring solution that has been on the market for several years, …
ORYZON to Host Virtual KOL Event on July 9, 2025
GlobeNewswire
·
June 25, 2025
MADRID and CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that it will host a virtual KOL event on …
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
GlobeNewswire
·
June 25, 2025
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Includes Positive Results from Phase 3 STRIVE-ON Safety Trial of GTx-104 Submission Has the Potential to Trigger …
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire
·
June 25, 2025
REDWOOD CITY, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today highlighted new data on VYKATTM XR (diazoxide …
BigCommerce and Feedonomics Team Up with Perplexity to Help Brands Excel at AI Product Search
GlobeNewswire
·
June 25, 2025
AUSTIN, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2C and B2B businesses, and Feedonomics, a leading data feed management solution, today announced their customers now have access to …
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
GlobeNewswire
·
June 25, 2025
SOUTH SAN FRANCISCO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the IND application submitted by its partner in China, Angel Pharmaceuticals Ltd. ( …
G2 Recognizes Regula as Identity Verification Leader with 100% Support Satisfaction
GlobeNewswire
·
June 25, 2025
RESTON, Va, June 25, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification solutions, has been recognized as a Leader in the G2 Grid® Report for Identity Verification | Summer 2025. Additionally, the company was …